Pediatric nephrology covers a wide range of kidney and urinary tract conditions that appear from before birth through adolescence, and these diseases collectively represent one of the most common reasons children develop kidney failure worldwide. Some are structural problems detectable on a prenatal ultrasound, others are immune-mediated conditions that strike an otherwise healthy toddler seemingly overnight, and still others are slow-burning metabolic disorders that quietly damage kidneys over years. What makes pediatric kidney disease distinct from its adult counterpart is not just the list of diagnoses but the way disease interacts with a body that is still growing, developing neurologically, and maturing physiologically.
Congenital Anomalies of the Kidney and Urinary Tract
The single largest category of kidney disease in children goes by the acronym CAKUT, for congenital anomalies of the kidney and urinary tract. These are structural problems that arise during fetal development and range from a kidney that simply sits in an unusual position to one that never forms at all. CAKUT is the most common cause of kidney failure in children worldwide.1PubMed Central. Congenital anomalies of the kidney and urinary tract: defining risk factors of disease progression and determinants of outcomes The spectrum includes conditions like vesicoureteral reflux (where urine flows backward from the bladder toward the kidneys), obstruction at the junction where the kidney meets its drainage tube, kidneys fused together, and kidneys that are severely underdeveloped or absent.
What causes CAKUT is still being worked out. Genetic mutations clearly play a role, with many genes now implicated in kidney and urinary tract development.2PubMed Central. A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT) But the picture is complicated because the same gene mutation can produce very different outcomes in different children, and changes in the maternal or fetal environment during pregnancy, along with physical obstruction in the developing urinary tract, also contribute.3PubMed Central. Congenital anomalies of the kidney and urinary tract: defining risk factors of disease progression and determinants of outcomes Many children with mild CAKUT do well with monitoring alone, but severe forms can lead to progressive kidney damage requiring dialysis or transplant during childhood.
Nephrotic Syndrome
Nephrotic syndrome is one of the most recognizable pediatric kidney conditions. A child, usually between the ages of one and twelve, develops puffy eyelids and swollen ankles because the kidney’s filtering units are leaking large amounts of protein into the urine. The protein loss drops blood protein levels, and fluid that would normally stay in the bloodstream seeps into surrounding tissues. The good news is that the vast majority of children respond to steroid treatment: roughly 85% achieve complete remission of protein leakage after a course of glucocorticoids.4PubMed Central. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
The children who do not respond within four to six weeks of steroid therapy are classified as having steroid-resistant nephrotic syndrome, and this is where things get harder. In roughly 10 to 30 percent of steroid-resistant cases, doctors can identify mutations in genes responsible for the structure of podocytes, the specialized cells that form the kidney’s filtration barrier.5PubMed Central. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome One study that performed genetic testing across all age groups found mutations in about a third of steroid-resistant patients overall, but the detection rate varied dramatically by age of onset: every patient with disease appearing at birth carried a mutation, while detection dropped to about 14% in adults.6PubMed Central. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome Knowing whether a genetic cause is present matters practically, because genetically driven cases almost never respond to immunosuppressive drugs and may recur after transplant, whereas immune-mediated cases often do respond to alternative medications.
IgA Vasculitis Nephritis
IgA vasculitis, still commonly called Henoch-Schönlein purpura, is a condition where small blood vessels become inflamed, typically producing a distinctive rash on the legs and buttocks, joint pain, abdominal symptoms, and sometimes kidney involvement. When the kidneys are affected, the condition is called IgA vasculitis nephritis, and it is one of the more common forms of glomerulonephritis in children. Most children with mild kidney involvement, such as isolated blood in the urine or minor protein loss, tend to do well. A meta-analysis found that children whose initial kidney presentation was limited to blood in the urine or mild proteinuria were significantly more likely to have a good long-term outcome.7PLOS ONE. Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis
The concern is when kidney involvement is more severe. Children who present with features of nephrotic syndrome or who have crescent formation on kidney biopsy face a meaningfully higher risk of poor outcomes.8PLOS ONE. Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis European pediatric guidelines now recommend starting steroids earlier than older guidelines suggested, even for children with moderate proteinuria, in hopes of preventing progression.9Child Kidney Dis. Management of IgA vasculitis nephritis (Henoch-Schonlein purpura nephritis) in Children
Hemolytic Uremic Syndrome
Hemolytic uremic syndrome, or HUS, is a dramatic illness in which red blood cells are destroyed, platelets drop, and the kidneys are acutely injured. The classic form follows infection with Shiga toxin-producing E. coli, often from contaminated food. Young children under three are especially vulnerable, and certain toxin subtypes dramatically increase the risk of developing HUS after infection.10PubMed Central. Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children: incidence, risk factors, and clinical outcome In one large study, about two-thirds of affected children needed dialysis and a third developed significant neurological symptoms, though the majority eventually recovered kidney function over several years of follow-up.11PubMed Central. Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children: incidence, risk factors, and clinical outcome There is no specific treatment for the classic Shiga toxin form; supportive care and early intravenous fluids remain the mainstay.12Current Pediatrics Reports. Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome
Atypical HUS is a different story. It is caused not by infection but by genetic defects in the complement system, part of the immune response. Before targeted therapy existed, many children with atypical HUS progressed to permanent kidney failure. That changed with eculizumab, a drug that blocks the runaway complement activity driving the disease. In a prospective pediatric trial, most treated children achieved normalization of their blood counts, and the majority of those who needed dialysis at the start were able to stop it.13PubMed. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome Eculizumab is now recommended as first-line therapy for children with atypical HUS.14PubMed Central. Atypical hemolytic uremic syndrome and eculizumab therapy in children
Acute Kidney Injury in Hospitalized Children
Acute kidney injury, or AKI, refers to a sudden drop in kidney function. In children, this happens most often during critical illness. Studies from pediatric intensive care units report that anywhere from about 12% to over 40% of critically ill children develop AKI during their stay, with the wide range reflecting differences in how sick the patients were and which definition was used.15PubMed Central. Incidence, outcomes, and mortality risk factors of acute kidney injury in critically ill children: a tertiary care center study in Saudi Arabia16PubMed Central. Acute kidney injury in Pediatric Intensive Care Unit: Incidence, risk factors, and outcome Common triggers include sepsis, multi-organ failure, severe dehydration, and exposure to medications that are toxic to the kidneys.
How long AKI lasts matters as much as how severe it is. One study of over a thousand critically ill children found that those whose kidney injury resolved within 48 hours had a hospital mortality of about 5%, compared to about 18% in those whose injury persisted longer.17Pediatric Critical Care Medicine. Association Between Acute Kidney Injury Duration and Outcomes in Critically Ill Children The problem with catching AKI early is that the standard blood test, serum creatinine, rises only after significant damage has already occurred. Newer biomarkers like NGAL, which is released from injured kidney tubular cells within hours, are being studied as earlier warning signals.18PubMed Central. Novel acute kidney injury biomarkers and their utility in children and adolescents-overview None have yet replaced creatinine in routine clinical practice, but they are increasingly used in research settings and high-risk situations.
Tubular Disorders and Kidney Stones
Not all pediatric kidney diseases involve the filtering units. The tubules, the long tubes that process the fluid after filtration, can have their own problems. Renal tubular acidosis is a group of conditions where the kidneys fail to properly regulate acid in the blood. In the distal form, children develop metabolic acidosis, low potassium, excess calcium in the urine, and calcium deposits in the kidneys. Mutations in specific genes that encode components of the acid-pumping machinery in the collecting duct are responsible.19PubMed. Clinical and molecular aspects of distal renal tubular acidosis in children Diagnosis can be tricky because about two-thirds of children initially show features mimicking a different tubular disorder, but those features disappear once the acidosis is corrected with alkali therapy.20PubMed. Clinical and molecular aspects of distal renal tubular acidosis in children
Proximal renal tubular acidosis involves the upstream part of the tubule and, in children, often appears alongside a broader pattern of tubular dysfunction called Fanconi syndrome, where the kidneys also waste phosphate, glucose, uric acid, and amino acids. When Fanconi syndrome is present, it usually signals an underlying systemic condition that needs to be identified.21PubMed. Clinical Approach to Proximal Renal Tubular Acidosis in Children
Kidney stones in children were once considered rare but are increasingly recognized. Dietary shifts, rising obesity, higher sodium intake from processed foods, increased consumption of fructose-containing drinks, and lower water intake are all believed to be contributing.22PubMed. Kidney Stones in Children: Causes, Consequences, and Concerns There is also a growing appreciation for genetic causes. Heritability of kidney stone disease may be as high as 50%, and about 40 genes linked to single-gene disorders that cause stones have now been identified.23PubMed Central. Genetics of kidney stones and the role of genetic testing in prevention: a guide for urologists Next-generation genetic sequencing is making it easier to find a specific genetic cause in children who form stones repeatedly, which in turn can guide treatment and prevention in ways that were not possible a decade ago.
Cystic Kidney Diseases
Autosomal recessive polycystic kidney disease, or ARPKD, typically presents in infancy or early childhood and is distinct from the much more common adult-onset dominant form. Children with ARPKD develop enlarged kidneys filled with small cysts, but the condition also affects the liver, causing abnormal bile duct development that leads to liver fibrosis. Portal hypertension, which is elevated pressure in the liver’s blood supply, develops in a substantial proportion of children: in one long-term follow-up of 50 patients, it was diagnosed in 58%.24PubMed. Long-term kidney and liver outcome in 50 children with autosomal recessive polycystic kidney disease Complications of the liver involvement can include bleeding from swollen veins in the esophagus, recurrent bile duct infections, and difficulty absorbing fat-soluble vitamins.25PubMed Central. New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications Because both organs are affected, some children ultimately need combined kidney-liver transplantation. Liver function tests often remain normal even as the structural liver disease progresses, which means normal bloodwork does not rule out significant hepatic complications.
How Chronic Kidney Disease Affects Growth and the Heart
When kidney disease persists and becomes chronic, it takes a toll on the growing child’s body in ways that go beyond the kidneys themselves. Growth failure is one of the most visible consequences. Children with chronic kidney disease are not lacking growth hormone in the way someone with a pituitary problem would be; instead, their bodies become resistant to the growth hormone they produce. The kidneys play a role in processing growth signals, and as kidney function declines, those signals get blunted at multiple levels.26PubMed Central. Growth hormone axis in chronic kidney disease
Treatment with recombinant human growth hormone can counteract this resistance and promote catch-up growth. A controlled study followed children with chronic kidney disease who received growth hormone therapy through to final adult height. Treated boys reached a mean final height of 165 cm and girls 156 cm, an improvement of about 1.4 standard deviations above where they started. Untreated children, by contrast, continued to fall further behind, ending up about 0.6 standard deviations shorter than their baseline.27PubMed. Effect of growth hormone treatment on the adult height of children with chronic renal failure Growth hormone therapy is considered safe and effective for children with kidney disease and short stature, though final adult height still tends to fall somewhat below what genetics would predict.28PubMed Central. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease
Cardiovascular disease is the other major threat. Even in childhood, early markers of heart damage and blood vessel stiffening are frequently present in children with chronic kidney disease, especially those on dialysis.29PubMed Central. Cardiovascular disease in children with chronic kidney disease Thickening of the heart’s left ventricle, stiffened carotid arteries, and even coronary artery calcification have been documented. This is one reason why managing blood pressure aggressively in children with kidney disease is considered essential, and ambulatory blood pressure monitoring, where a child wears a portable cuff for 24 hours, has been shown to be more predictive of organ damage than isolated office measurements.30PubMed. Ambulatory Blood Pressure Monitoring in Pediatrics
Kidney Transplantation and Dialysis in Children
When kidney disease progresses to the point where the kidneys can no longer sustain life, the options are dialysis or transplantation. In children, transplantation is the preferred long-term treatment, and outcomes are generally favorable: ten-year patient survival after a pediatric kidney transplant exceeds 90%.31PubMed Central. Long-Term Outcomes of Kidney Transplantation in Children The focus of long-term management shifts to maintaining quality of life, preventing rejection, and minimizing the side effects of immunosuppressive drugs. Steroids, traditionally a backbone of post-transplant immunosuppression, carry well-known downsides in children, including impaired growth, weight gain, and metabolic changes. Some centers have experimented with steroid-avoidance protocols and found similar rejection rates at one year compared to steroid-based regimens, with a modest early survival benefit for the transplanted kidney, though the advantage did not persist beyond the first two years.32Nephrology Dialysis Transplantation. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance—a propensity score-matched study
Not all children are equal in their transplant prospects. Older children and adolescents tend to have lower ten-year graft survival than younger recipients, and the disparity worsens as age increases. African American recipients and children on dialysis at the time of transplant also face worse outcomes, while those with private insurance status show higher graft survival.33PubMed. Factors associated with long-term graft survival in pediatric kidney transplant recipients These disparities point to the role of adherence, access to care, and socioeconomic factors in long-term transplant success, beyond the biology of the kidney itself.
For very small or very young patients, dialysis presents unique challenges. Peritoneal dialysis, where fluid is cycled through the abdominal cavity to remove waste, is the most common form for infants, but catheter complications are frequent. In infants, leakage around the catheter site, blockage, and catheter migration are all common, and placing the catheter before the baby is a month old or using it within three days of placement significantly increases the risk of failure.34PubMed Central. Peritoneal dialysis catheter outcomes in infants initiating peritoneal dialysis for end-stage renal disease In the smallest and sickest babies, outcomes remain sobering despite advances in technique.
Neurodevelopment and Quality of Life
A dimension of pediatric kidney disease that families often do not anticipate is its effect on brain development. Most children with mild to moderate chronic kidney disease do not show dramatic global cognitive deficits, but subtle problems are common: average to slightly below-average IQ scores, and specific difficulties with attention and executive function that can create real barriers in school and social settings.35PubMed Central. The brain in pediatric chronic kidney disease – the intersection of cognition, neuroimaging, and clinical biomarkers These deficits often fly under the radar because the child does not appear profoundly impaired, yet they can meaningfully affect academic performance and daily functioning.
The effects are more pronounced at the severe end of the spectrum. Infants and toddlers awaiting kidney transplant scored well below age norms on standardized tests of cognition, language, and motor skills, and children on dialysis fared significantly worse than those not yet on dialysis.36PubMed. Neurodevelopment profile of infants and toddlers awaiting a kidney transplant A case-control study confirmed that neurocognitive function declined with advancing disease stage, with children at the most severe stage scoring the lowest.37PubMed Central. Neurodevelopmental Outcomes in Early Childhood Chronic Kidney Disease: Evidence from a Case-control Study Early recognition and developmental support are important because some of these deficits may be partially reversible, especially after successful transplantation, but catching them requires proactive screening rather than waiting for a child to fail at school.
Low Birth Weight and the Origins of Kidney Vulnerability
Kidney disease in children does not always start with an obvious diagnosis. An adverse environment before birth can set the stage for kidney problems that surface years or even decades later. Low birth weight, prematurity, and intrauterine growth restriction are all associated with an increased risk of high blood pressure and kidney disease in adulthood.38PubMed. Birth weight, malnutrition and kidney-associated outcomes–a global concern A key reason is that these stressors reduce the number of nephrons, the kidney’s functional units, that form before birth. Humans do not make new nephrons after birth, so a baby born with fewer nephrons starts life with less kidney reserve.
With fewer nephrons, each one has to work harder, a process that over time causes wear and tear, protein leakage into the urine, and accelerated loss of kidney function.39PubMed. Low birth weight, nephron number, and kidney disease This is not a purely theoretical concern. Maternal nutrition, fetal exposure to diabetes, and rapid weight gain in early childhood are all recognized contributors to nephron programming effects.40PubMed. Birth weight, malnutrition and kidney-associated outcomes–a global concern The implications are relevant for pediatricians and families alike: children born prematurely or small may benefit from periodic blood pressure and urine screening throughout childhood, even if they seem perfectly healthy.
Transitioning from Pediatric to Adult Care
One of the most dangerous periods for a young person with chronic kidney disease or a kidney transplant is the handoff from pediatric to adult care. Adolescents and young adults are already at higher risk of graft loss than other age groups, partly because medication adherence tends to decline as teens gain independence and partly because the move to a new medical team often means gaps in follow-up. Structured transition programs aim to bridge this gap, and evidence-based transition protocols have been linked to better medication adherence, fewer missed appointments, and lower rejection rates.41PubMed Central. Transition of care from pediatric to adult nephrology post-renal transplant: a review
Drug Dosing in a Changing Body
A practical reality of treating kidney disease in children is that drug dosing cannot simply be scaled down from adult guidelines. The way children absorb, distribute, metabolize, and excrete medications changes continuously as they grow, meaning a dose that works for a six-month-old may be too little for a two-year-old and too much for a newborn.42PubMed Central. Developmental pharmacokinetics in pediatric populations Kidney function itself is not mature at birth; glomerular filtration rate increases rapidly in the first weeks of life and does not reach adult levels until roughly two years of age. For children who already have impaired kidneys, the usual age-based dosing curves may not apply, requiring careful individualized adjustments. This is part of why pediatric nephrology exists as its own subspecialty: managing kidney disease in a body whose physiology is a moving target demands expertise that does not translate directly from adult practice.